JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB326102

Anti-HERV-FRD antibody [EPR30312-632]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal HERV-FRD antibody. Suitable for IP, ICC/IF, IHC-P, WB and reacts with Human samples.

View Alternative Names

ERVFRDE1, UNQ6191/PRO20218, ERVFRD-1, Syncytin-2, Endogenous retrovirus group FRD member 1, Envelope polyprotein, HERV-FRD, HERV-FRD_6p24.1 provirus ancestral Env polyprotein

6 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HERV-FRD antibody [EPR30312-632] (AB326102)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HERV-FRD antibody [EPR30312-632] (AB326102)

Immunohistochemical analysis of paraffin-embedded Human placenta tissue labeling HERV-FRD with ab326102 at 1/50 (9.94 µg/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Cytoplasmic staining in human placenta (PMID : 18215254; PMID : 18988732).

The primary antibody was incubated for 30 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins

Immunocytochemistry/ Immunofluorescence - Anti-HERV-FRD antibody [EPR30312-632] (AB326102)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-HERV-FRD antibody [EPR30312-632] (AB326102)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized JEG-3 (human placenta epithelial cell) HeLa (human cervical adenocarcinoma epithelial cell) cells labelling HERV-FRD with ab326102 at 1/50 (9.94 µg/ml) dilution , followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 dilution (Green).

Confocal image showing membranous staining in JEG-3 cell line and no staining in HeLa cell line(shown in green). The counterstain was observed in magenta. Nuclear DNA was labelled with DAPI (shown in blue). Negative control : HeLa. Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

ab7291 Anti-alpha Tubulin mouse monoclonal antibody was used to counterstain tubulin at 1/1000 dilution (Magenta). The Nuclear counterstain was DAPI (Blue).

-ve control 1 : ab326102 at 1/50 dilution, followed by ab150120 at 1/1000 dilution.-ve control 2 : ab7291 at 1/1000 dilution, followed by ab150081 at 1/1000 dilution.

Immunoprecipitation - Anti-HERV-FRD antibody [EPR30312-632] (AB326102)
  • IP

Lab

Immunoprecipitation - Anti-HERV-FRD antibody [EPR30312-632] (AB326102)

HERV-FRD was immunoprecipitated from 0.35 mg JEG-3 (Human placenta epithelial choriocarcinoma) whole cell lysate with ab326102 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab326102 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.

Lane 1 : JEG-3 (Human placenta epithelial choriocarcinoma) whole cell lysate
Lane 2 : ab326102 IP in JEG-3 (Human placenta epithelial choriocarcinoma) whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab326102 in JEG-3 whole cell lysate

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 26 seconds.

All lanes:

Immunoprecipitation - Anti-HERV-FRD antibody [EPR30312-632] (ab326102) at 1/1000 dilution

Lane 1:

JEG-3 (Human placenta epithelial choriocarcinoma) whole cell lysate at 10 µg

Lane 2:

ab326102 at 1/30 IP in JEG-3 (Human placenta epithelial choriocarcinoma) whole cell lysate

Lane 3:

Rabbit monoclonal IgG (<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>) instead of ab326102 in JEG-3 whole cell lysate

Secondary

All lanes:

Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution

Observed band size: 59 kDa,70 kDa

false

Exposure time: 26s

Western blot - Anti-HERV-FRD antibody [EPR30312-632] (AB326102)
  • WB

Lab

Western blot - Anti-HERV-FRD antibody [EPR30312-632] (AB326102)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Low expression : kidney, liver, small intestine (PMID : 10693809)

The molecular weight observed is consistent with what has been described in the literature (PMID : 35596004; PMID : 18650494).

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).

All lanes:

Western blot - Anti-HERV-FRD antibody [EPR30312-632] (ab326102) at 1/1000 dilution

Lane 1:

Human kidney tissue lysate at 20 µg

Lane 2:

human liver tissue lysate at 20 µg

Lane 3:

Human small intestine tissue lysate at 20 µg

Lane 4:

human placenta tissue lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Observed band size: 59 kDa,70 kDa,36 kDa

false

Exposure time: 26s

Western blot - Anti-HERV-FRD antibody [EPR30312-632] (AB326102)
  • WB

Lab

Western blot - Anti-HERV-FRD antibody [EPR30312-632] (AB326102)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Negative control : HeLa

The molecular weight observed is consistent with what has been described in the literature (PMID : 35596004; PMID : 18650494).

HERV-FRD is a glycoprotein of approximately 59 and 70 kDa and is detected as 37 kDa and 50 kDa band after treatment with the deglycosylation enzyme Peptide : N-glycosidase F (PNGase F)(Lane 4).

Lanes 3-4 of this blot was developed using a high-sensitivity ECL substrate, allowing for the detection of proteins in the mid-femtogram range.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).

All lanes:

Western blot - Anti-HERV-FRD antibody [EPR30312-632] (ab326102) at 1/1000 dilution

Lane 1:

JEG-3 (human placenta epithelial cell) whole cell lysate at 48 µg

Lane 2:

HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 48 µg

Lane 3:

Untreated JEG-3 (human placenta epithelial cell) whole cell lysate at 48 µg

Lane 4:

JEG-3 lysate treated with Protein Deglycosylation Peptide:N-glycosidase F (PNGase F) at 48 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 59 kDa,70 kDa,36 kDa

true

Exposure time: 180s

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HERV-FRD antibody [EPR30312-632] (AB326102)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HERV-FRD antibody [EPR30312-632] (AB326102)

Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling HERV-FRD with ab326102 at 1/50 (9.94 µg/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Low expression : Negative staining in human kidney (PMID : 10693809).

The primary antibody was incubated for 30 mins at room temperature.

The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).

Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR30312-632

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, IP, WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The immunogen used shares no sequence similarity with members of HERV-FRD. Based on the immunogen sequence analysis, we do not expect this antibody to cross-react with members of HERV-FRD. No cross-reactivity testing has been performed.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

This endogenous retroviral envelope protein has retained its original fusogenic properties and participates in trophoblast fusion and the formation of a syncytium during placenta morphogenesis. The interaction with MFSD2A is apparently important for this process (PubMed : 18988732).. Endogenous envelope proteins may have kept, lost or modified their original function during evolution but this one can still make pseudotypes with MLV, HIV-1 or SIV-1 virions and confer infectivity. Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. The surface protein mediates receptor recognition, while the transmembrane protein anchors the envelope heterodimer to the viral membrane through one transmembrane domain. The other hydrophobic domain, called fusion peptide, mediates fusion of the viral membrane with the target cell membrane (PubMed : 14694139).
See full target information ERVFRD-1

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com